Reducing the Risks of HIV Research

When the annual meeting of the American Association for the Advancement of Science opens in Boston later this week, eight of its scores of sessions will deal with AIDS. That is far more attention than the meeting allocates to any other single topic. Even superconductivity, the glamour kid of science, gets only two. Despite all those days of discussion, judging by the condensed program available in advance of the meeting, the organizers have ignored a critical aspect of AIDS research: the safet

Written byTabitha Powledge
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Despite all those days of discussion, judging by the condensed program available in advance of the meeting, the organizers have ignored a critical aspect of AIDS research: the safety of the researchers who are trying to make it go away. As we reported in our last issue (THE SCIENTIST, .January 25, 1987 p. 1), it is not clear that current lab safety procedures offer enough protection against HIV infection, even then they are carefully observed. A two-year study of 265 lab workers, published in Science on New Year's Day, disclosed that one of them had become infected with HIV even though he or she-the worker remains anonymous-had no known risk factors and appears to have violated no safety procedures.

Now of course it may turn out that the infected really did do something, either inside or outside the lab, that led to infection by one of the obvious routes. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies